2
Views
3
CrossRef citations to date
0
Altmetric
Cell Growth and Development

A Mutation in the Putative Mg2+-Binding Site of Gs α Prevents Its Activation by Receptors

, , &
Pages 4830-4838 | Received 01 May 1991, Accepted 27 Jun 1991, Published online: 31 Mar 2023
 

Abstract

The properties of a Gs α mutant with an Asn substituted for Ser at position 54, designated mutant 54Asn αs, were studied after expression in S49 αs-deficient (cyc) cells. Ser-54 in αs is comparable to Ser-17 in Ras, which is involved in binding Mg2+ associated with bound nucleotide. 54Asn αs did not restore either hormone-induced cyclic AMP production in intact cyc cells or hormone-induced adenylyl cyclase activation in membranes isolated from these cells. The defect was a failure of ligand-bound receptor to activate 54Asn αs, since the mutant protein retained the ability to activate adenylyl cyclase in isolated membranes in the presence of GTP or GTPγS. Guanine nucleotide regulation of mutant αs suggested that it has increased guanine nucleotide exchange rates and an increased preference for diphosphates over triphosphates. Hormone stimulation magnified the preference of 54Asn αs for diphosphates, which could account for its inability to be activated by receptor. The properties of this mutant are discussed in terms of similarities to and differences with the analogous RasH mutant, which has been shown to interfere with endogenous Ras function in cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.